Clinical Trial Results:
A Single Centre, Open-Label Study to Evaluate the Immunogenicity and Safety of Enzira® vaccine in Healthy ‘Adults’ aged ≥ 18 to < 60 years and in Healthy ‘Older Adults’ aged ≥ 60 years for the 2008/2009 Northern Hemisphere Influenza Season
Summary
|
|
EudraCT number |
2008-001422-14 |
Trial protocol |
GB |
Global completion date |
19 Jun 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
15 Apr 2016
|
First version publication date |
15 Apr 2016
|
Other versions |
|
Summary report(s) |
CSL_CSLCT-NHF-07-49_Result_Summary-Final |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.